NR2F6 as a Prognostic Biomarker in HNSCC

NR2F6 as a Prognostic Biomarker in HNSCC

Head and neck squamous cell carcinoma (HNSCC)is the 6th most common cancer in humans worldwide and is associated with a poor prognosis for patients. NR2F6 has been identified as an immune checkpoint molecule in tumor-infiltrating T lymphocytes and is associated with a poor prognostic outcome in vari...

Full description

Bibliographic Details
Main Authors: Luise Klapper, Julika Ribbat-Idel, Patrick Kuppler, Finn-Ole Paulsen, Karl-Ludwig Bruchhage, Dirk Rades, Anne Offermann, Jutta Kirfel, Barbara Wollenberg, Christian Idel, Sven Perner
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
HNSCC
NR2F6
local recurrence
prognosis
recurrence-free survival
biomarker
Online Access:https://www.mdpi.com/1422-0067/21/15/5527

Internet

https://www.mdpi.com/1422-0067/21/15/5527

Similar Items